Dentsply Sirona (XRAY) Research & Development (2020 - 2026)

Dentsply Sirona (XRAY) has reported Research & Development for 7 consecutive years, with $45.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 21.62% year-over-year to $45.0 million; the trailing twelve-month figure through Jun 2026 stood at $166.0 million (up 7.1% YoY), and the FY2025 full-year result was $150.0 million, down 9.09% from the prior year.
• Research & Development advanced to $45.0 million in Q2 2026 per XRAY's latest filing, from $44.0 million in the prior quarter.
• Across five years, Research & Development topped out at $49.0 million in Q2 2023 and bottomed at $36.0 million in Q1 2025.
• Historically, Research & Development has averaged $42.3 million across 5 years, with a median of $42.5 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Research & Development declined 16.33% in 2024, then increased 22.22% in 2026.
• Over 5 years, Research & Development stood at $43.0 million in 2022, then changed by 0.0% to $43.0 million in 2023, then declined by 2.33% to $42.0 million in 2024, then declined by 4.76% to $40.0 million in 2025, then gained by 12.5% to $45.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $45.0 million, $44.0 million, and $40.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.